Literature DB >> 8252626

High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro.

C Abbadie1, N Kabrun, F Bouali, J Smardova, D Stéhelin, B Vandenbunder, P J Enrietto.   

Abstract

To determine the physiological processes in which the transcription factor c-Rel may act, we have examined its pattern of expression in the avian embryo by in situ hybridization. These studies showed that c-rel is expressed ubiquitously at low levels and at high levels in isolated cells undergoing programmed cell death by apoptosis or autophagocytosis. To further establish a functional link between expression of c-rel and cell death, we examined the biological consequences of c-rel overexpression in vitro. In primary avian fibroblasts, overexpression of c-rel leads to transformation and dramatic life span extension. In contrast, bone marrow cells expressing high levels of c-rel undergo a process of programmed cell death displaying features of both apoptosis and autophagocytic cell death. Thus, these experiments suggest a critical role for c-rel not only in the control of cell proliferation, but also in the induction of cell death.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252626     DOI: 10.1016/0092-8674(93)90534-w

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

1.  Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB.

Authors:  J Gil; J Alcamí; M Esteban
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 2.  NF-kappaB and apoptosis in mammary epithelial cells.

Authors:  R W Clarkson; C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

3.  Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.

Authors:  R F Guo; M Huber-Lang; X Wang; V Sarma; V A Padgaonkar; R A Craig; N C Riedemann; S D McClintock; T Hlaing; M M Shi; P A Ward
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

4.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

5.  Induction of apoptosis by the transcription factor c-Jun.

Authors:  E Bossy-Wetzel; L Bakiri; M Yaniv
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 6.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

Authors:  R J Grumont; I J Rourke; S Gerondakis
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

8.  Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

Authors:  J L Connolly; S E Rodgers; P Clarke; D W Ballard; L D Kerr; K L Tyler; T S Dermody
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.

Authors:  H C Liou; W C Sha; M L Scott; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease.

Authors:  Sean M O'Donnell; Mark W Hansberger; Jodi L Connolly; James D Chappell; Melissa J Watson; Janene M Pierce; J Denise Wetzel; Wei Han; Erik S Barton; J Craig Forrest; Tibor Valyi-Nagy; Fiona E Yull; Timothy S Blackwell; Jeffrey N Rottman; Barbara Sherry; Terence S Dermody
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.